DOPATREE
Preview
Open in TheBrain
DOPATREE
ORGANIZATIONS
COMPANIES-ALL (COMPANY, CLIENTS, SPONSORS, SMALL, MID-SIZE, LARGE PHARMA, BIG PHARMA, BIOPHARMA, EMERGING COMPANIES, STARTUPS, START-UPS, SPIN-OFFS, SUBSIDIARIES, SUBSIDIARY, BIOTECHNOLOGY, EMERGING)
COMPANIES / LISTINGS-N
NOVARTIS
NOVARTIS / PRODUCTS / APPROVED
GILENYA® (FINGOLIMOD)
GILENYA / MARKET ACCESS
Parents
GILENYA® (FINGOLIMOD)
Children
ICER. MULTIPLE SCLEROSIS : CIS, RRMS, AND SPMS. AN ASSESSMENT OF ORAL AND MONOCLONAL ANTIBODY TREATMENTS FOR RELAPSING FORMS OF MS. PUBLIC MEETING : JAN 2023.
ICER. MULTIPLE SCLEROSIS : RRMS AND PPMS. AN ASSESSMENT OF DISEASE MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS. PUBLIC MEETING : FEB 2017.